FLT3LG and neoplasm: Both DCP-IL-12/FLT3L and DCP-IL-12 enhanced tumor-associated macrophage (TAM) expression of MHCII (>90%; Fig. 2g and Extended Data Fig. 5d), indicating acquisition of an immunostimulatory (M1-like) phenotype24.